Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Lululemon Athletica Inc (LULU) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Lululemon Athletica IncTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Lululemon Athletica Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while Lululemon Athletica Inc trades at $94.08 (market cap $10.44B). The key difference: Lululemon Athletica Inc is far larger — about 2.6× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Lululemon Athletica Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Lululemon Athletica Inc for 106 Days on average.

INDVLULU
Market Cap
$4.03B$10.44B
Volume
2,781,1712,759,135
Sector
HealthConsumer Cyclical
52-Week High
$41.83$215.88
52-Week Low
$24.09$91.88
Typical Hold Time
0 Days106 Days
Enterprise Value
$4.32B$11.20B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Lululemon Athletica Inc

Lululemon stock trades at $94.34, near its 52-week low, reflecting a 54% decline year-to-date amid growth concerns and securities fraud investigations. The technical picture is bearish, with the stock below key moving averages. Fundamentally, the company maintains strong profitability with a 56.11% gross margin and 12.78% net margin, but revenue growth has slowed, and Q3 2026 earnings are pending. Analyst consensus is mixed, with a Hold rating predominant and a $97.67 price target.

The outlook is cautious due to competitive pressures, governance scrutiny, and potential legal liabilities. While valuation metrics like a P/E of 7.76 appear attractive, near-term risks from weakening fundamentals and negative sentiment may limit upside. Recovery hinges on reversing revenue trends and resolving legal overhangs, making the stock speculative for now.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
LULU
29% Buy71% Sell
Avg holding period · 106 Days

Top news

Latest headlines on both assets

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Lululemon Athletica Inc

Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.

Read more on LULU →